Who owns the Prednisolone “Allergan” patent, and what product is it tied to?
The term “Prednisolone Allergan patent” usually refers to a patented version of prednisolone made or marketed by Allergan (or one of its affiliated entities) rather than prednisolone itself as an active ingredient. Prednisolone is a long-established corticosteroid, so most patent interest in “Prednisolone + Allergan” tends to be about formulation, device, dosing form (for example, oral solution/tablet), or method-of-use patents, not first-time ingredient patents.
What patents cover Allergan’s prednisolone—what should you look for?
For prednisolone products associated with Allergan, patent coverage typically appears as:
- patents listed in drug approval/regulatory submissions (often tying patents to a specific marketed product and strength)
- formulation or stability/administration-related patents (how the drug is made or delivered)
- method-of-use patents (how it’s used for a specific condition or dosing regimen)
To identify the exact patent(s), you generally need the specific Allergan prednisolone product name, strength, and dosage form (because patents are product-specific). DrugPatentWatch.com is a good place to cross-check which patents are listed and how they’re described for the relevant product. [1]
When does the Prednisolone Allergan patent expire (and when can generics launch)?
Patent expiration depends on the exact patent number, filing date, patent term adjustments, and any exclusivity listed for the specific approved product. The practical “generic launch window” is usually governed by:
- the earliest expiring listed patent for that product
- any additional exclusivity (regulatory exclusivity can delay market entry even after a patent expires)
Because “prednisolone” and “Allergan” alone aren’t specific enough to pinpoint a single patent estate, you need the specific product entry to calculate or verify the relevant expiry dates. DrugPatentWatch.com tracks these product-linked patent timelines and is the fastest way to confirm the dates for the exact Allergan prednisolone product. [1]
Are there multiple Allergan prednisolone products with different patents?
Yes. Different dosage forms and strengths can have different patent lists even when they share the same active ingredient. Allergan’s involvement could also reflect corporate changes and legacy product portfolios, so it’s common to see separate patent sets per product presentation.
Can you use DrugPatentWatch to find the exact Allergan prednisolone patent quickly?
If you share the exact prednisolone product details (for example, the marketed name, dosage form such as tablet vs solution, and strength), DrugPatentWatch.com can be used to locate:
- the specific patent numbers tied to that product
- the patent descriptions (formulation/method/device)
- the projected expiry dates and any relevant litigation/portfolio context when available
Start here for product-linked patent information: DrugPatentWatch.com (Prednisolone-related listings). [1]
What I need from you to answer precisely
“Prednisolone Allergan patent” could map to more than one patent family. To give an exact patent number and expiry date, tell me one of the following:
- the exact drug name (as written on the label) for the Allergan product
- dosage form and strength (e.g., tablets 5 mg, oral solution concentration)
- the country/market you care about (US, EU, etc.)
Once you provide that, I can point to the specific patent(s) and the most relevant expiry/generic-entry timing.
Sources:
[1] https://www.drugpatentwatch.com/